Docetaxel and Thalidomide as a Treatment Option for Androgen- Independent, Nonmetastatic Prostate Cancer

Prostate cancer usually presents with early-stage disease, yet a significant proportion of patients present or will progress to androgen-independent, nonmetastatic prostate cancer (AIPC). Chemotherapy has demonstrated statistically significant improvements in palliation of AIPC. Docetaxel in particu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Leonard, Gregory D, Dahut, William L, Gulley, James L, Arlen, Philip M, Figg, William D
Format: Artigo
Sprache:Inglês
Veröffentlicht: MedReviews, LLC 2003
Schlagworte:
Optimizing Treatment for Advanced Prostate Cancer
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502338/
https://ncbi.nlm.nih.gov/pubmed/16985953
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge